Randy Spaulding

In 2007, Randol R. Spaulding founded Spaulding Clinical Pharmacology. At present, Spaulding Clinical Pharmacology has over 200 employees and boasts the most technologically advanced, fully-automated Research Unit in the world, with data quality unmatched by competitors. While establishing the Clinical Pharmacology unit, Randy seized the opportunity to further enhance clinical research by designing a new ECG device. In 2010, he opened Spaulding Core Labs, a Cardiac Safety testing center for new drugs under development.

With the launch of Spaulding iQTM in 2011 – Spaulding Clinicals handheld, proprietary ECG device – the company quickly caught global attention. Spaulding Medical was formed in 2015, taking this leading ECG technology into the healthcare market. Between all business units, Randy employs over 240 people and is driving year-over-year growth at a rate of 100%. In 2012 he was named “CEO of the Year” for Southeastern Wisconsin, in 2011 named provider of “Best Company Direction,” and Spaulding Clinical was acclaimed as a “Top 5 Workplace” for 2011 and 2012.